Brexit: Vital Strategies For Keeping Devices On EU And UK Markets
Executive Summary
As the Brexit clock ticks, fewer organizations are willing to risk waiting for the political fog to clear, preferring to act now. Lawyer Alison Dennis spells out practical survival strategies.
You may also be interested in...
'Hard' Brexit And Damage To MHRA's EU Medtech Reg Role Causing UK Concern
Few it seems want the UK MHRA to lose its strong input into EU medtech regulatory affairs. But the UK's brinkmanship on a hard Brexit and refusal to countenance any jurisdiction for the European Court of Justice post-Brexit could spell a severely diminished role for the UK health care regulator in EU matters after March 2019.
UK's Brexit Could Result In Fewer, Less-Safe Devices
The UK is putting patients at risk of serious safety issues when it comes to Brexit. Attorney Alison Dennis explains why the UK health sector may have fewer, and less-safe devices after March 2019
Contradictory Messages Over Medtech and Brexit: MDR? No MDR?
Nearly 16 months after the Brexit vote, uncertainty persists over whether the EU's Medical Device and IVD Regulations will be adopted by the UK. Stakeholders tried to wade through the morass at two recent London meetings.